Axogen, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Axogen, Inc. (AXGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $8.93 per share for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2020-05-06
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-03-31 was $8.93, a 28.27% decline year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2019-03-31 was $12.45, a 11.64% decline year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2018-03-31 was $14.09, a 166.86% increase year-over-year.
- Axogen, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2017-03-31 was $5.28, a 2.92% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month |
|---|---|---|---|---|
| 2020-03-31 | $8.93 10-Q · filed 2020-05-06 | |||
| 2019-09-30 | $15.78 10-Q · filed 2019-11-06 | |||
| 2019-06-30 | $19.13 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $12.45 10-Q · filed 2020-05-06 | |||
| 2018-09-30 | $26.19 10-Q · filed 2019-11-06 | |||
| 2018-06-30 | $24.45 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | $14.09 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | $6.77 10-Q · filed 2018-10-29 | |||
| 2017-06-30 | $11.41 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $5.28 10-Q · filed 2018-04-30 | $10.55 10-Q · filed 2017-05-04 | ||
| 2016-09-30 | $3.00 10-Q · filed 2017-11-01 | |||
| 2016-06-30 | $5.16 10-Q · filed 2017-08-02 | |||
| 2016-03-31 | $5.13 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |